Altimmune, Inc. ALT
Set alert
2.04 USD -0.10 -4.67%
At close · Oct 30
2.07 +0.03 +1.47%
After hours · Oct 30, 7:12 PM ET
1.99 Day range 2.13
2.04 52-week range 6.18
- YTD
- -43.49%
- 1 year
- -49.88%
- Open
- 2.10
- Prev close
- 2.14
- Mkt cap
- 396.82M
- Vol
- 3.52M
- Avg vol
- 4.05M
- EPS
- -0.76
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.99
- High
- 2.13
- Forward P/E
- -5.14
- Beta
- 0.07
- Short ratio
- 5.81
- Inst. own
- 56.68%
- Dividend
- 0.00
- Ex-div date
- Jan 19, 2017
- 50-d avg
- 7.91
- 200-d avg
- 7.41
- 1y target
- 22.86
MAX chart
Events in this range
- Nov 7, 2023Earnings: -0.39; estimate -0.4; surprise 2.5%
Signals (35)
| Name | Date | Ago |
|---|---|---|
| MACD: Sell Signal | Mar 1, 2026 | 8 months ago |
| SMA: Bearish | Feb 1, 2026 | 9 months ago |
| SMA: Bullish | Jan 1, 2026 | 10 months ago |
| MACD: Buy Signal | Jan 1, 2026 | 10 months ago |
| SMA: Bearish | Dec 1, 2025 | 11 months ago |
| SMA: Bullish | Nov 1, 2025 | 1 year ago |
| MACD: Sell Signal | Apr 1, 2025 | 1 year ago |
| SMA: Bearish | Dec 1, 2024 | 1 year ago |
| SMA: Bearish | Dec 1, 2024 | 1 year ago |
| SMA: Bullish | Nov 1, 2024 | 2 years ago |
| SMA: Bullish | Nov 1, 2024 | 2 years ago |
| SMA: Bearish | Jun 1, 2024 | 2 years ago |
| SMA: Bearish | Apr 1, 2024 | 2 years ago |
| SMA: Bullish | Dec 1, 2023 | 2 years ago |
| SMA: Bullish | Dec 1, 2023 | 2 years ago |
| MACD: Buy Signal | Dec 1, 2023 | 2 years ago |
| SMA: Bearish | Mar 1, 2023 | 3 years ago |
| MACD: Sell Signal | Mar 1, 2023 | 3 years ago |
| SMA: Bearish | Feb 1, 2023 | 3 years ago |
| SMA: Bullish | Dec 1, 2022 | 3 years ago |
| SMA: Bullish | Dec 1, 2022 | 3 years ago |
| SMA: Bearish | Nov 1, 2022 | 4 years ago |
| SMA: Bearish | Nov 1, 2022 | 4 years ago |
| SMA: Bullish | Jun 1, 2022 | 4 years ago |
| SMA: Bullish | Jun 1, 2022 | 4 years ago |
| MACD: Buy Signal | Jun 1, 2022 | 4 years ago |
| MACD: Sell Signal | Mar 1, 2022 | 4 years ago |
| SMA: Bearish | Dec 1, 2021 | 4 years ago |
| SMA: Bearish | Sep 1, 2021 | 5 years ago |
| SMA: Bullish | Aug 1, 2021 | 5 years ago |
| SMA: Bearish | Mar 1, 2021 | 5 years ago |
| SMA: Bullish | Jan 1, 2021 | 5 years ago |
| SMA: Bearish | Dec 1, 2020 | 5 years ago |
| SMA: Bullish | Jun 1, 2020 | 6 years ago |
| SMA: Bullish | Feb 1, 2020 | 6 years ago |
Financial health
Altman Z-Score
2.80 Grey zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C+2 / 5 overall
- DCF 2
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 3
- P/E 1
- P/B 4
Valuation
P/E -3.6×
FY 2016 5y median -5.4× FY 2025
P/S 7757×
FY 2016 5y median 1406× FY 2025
P/B 1.4×
FY 2016 5y median 3.1× FY 2025
P/FCF -4.7×
FY 2016 5y median -6.4× FY 2025
EV/EBITDA -3.6×
FY 2016 5y median -5.0× FY 2025
EV/Sales 7561×
FY 2016 5y median 1091× FY 2025
FCF Yield -21.2%
FY 2016 5y median -15.6% FY 2025
Profitability
Gross Margin 100.0%
FY 2016 5y median 100.0% FY 2025
Operating Margin -230461.0%
FY 2016 5y median -22518.5% FY 2025
Net Margin -214861.0%
FY 2016 5y median -20762.2% FY 2025
ROE -39.2%
FY 2016 5y median -45.7% FY 2025
ROIC -35.4%
FY 2016 5y median -48.2% FY 2025
ROA -31.5%
FY 2016 5y median -42.0% FY 2025
Growth (YoY)
Revenue 105.0%
FY 2016 FY 2025
Operating Income 8.4%
FY 2016 FY 2025
EPS (diluted) 25.4%
FY 2016 FY 2025
Free Cash Flow 15.4%
FY 2016 FY 2025
Financial Health
Current Ratio 18.5×
FY 2016 5y median 13.1× FY 2025
Quick Ratio 18.5×
FY 2016 5y median 13.1× FY 2025
Debt / Equity 0.2×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 0.1×
FY 2016 5y median 1.3× FY 2025
Interest Coverage -57.8×
FY 2016 5y median -10968× FY 2025
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31